P
Palisade Bio D
D
PALI
2.37000
USD
-0.08
(-3.27%)
Market Closed
Volume
624
EPS
-13
Div Yield
-
P/E
-0
Market Cap
3,624,953
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news
More
Title: Palisade Bio
Sector: Healthcare
Industry: Biotechnology
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.